RVP vs. AKLI, CODX, GBS, ICU, MDAI, NMTC, MODD, FEMY, CTCX, and IINN
Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include Akili (AKLI), Co-Diagnostics (CODX), GBS (GBS), SeaStar Medical (ICU), Spectral AI (MDAI), NeuroOne Medical Technologies (NMTC), Modular Medical (MODD), Femasys (FEMY), Carmell (CTCX), and Inspira Technologies Oxy B.H.N. (IINN). These companies are all part of the "surgical & medical instruments" industry.
Akili (NASDAQ:AKLI) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation, community ranking and media sentiment.
Akili currently has a consensus target price of $4.00, suggesting a potential upside of 839.85%. Given Retractable Technologies' higher possible upside, equities research analysts clearly believe Akili is more favorable than Retractable Technologies.
Akili has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 2.11, meaning that its stock price is 111% more volatile than the S&P 500.
Retractable Technologies has higher revenue and earnings than Akili. Retractable Technologies is trading at a lower price-to-earnings ratio than Akili, indicating that it is currently the more affordable of the two stocks.
Akili received 6 more outperform votes than Retractable Technologies when rated by MarketBeat users. Likewise, 66.67% of users gave Akili an outperform vote while only 0.00% of users gave Retractable Technologies an outperform vote.
Retractable Technologies has a net margin of -18.84% compared to Retractable Technologies' net margin of -2,492.04%. Akili's return on equity of -7.55% beat Retractable Technologies' return on equity.
53.1% of Akili shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 10.1% of Akili shares are held by company insiders. Comparatively, 55.0% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Retractable Technologies had 4 more articles in the media than Akili. MarketBeat recorded 8 mentions for Retractable Technologies and 4 mentions for Akili. Retractable Technologies' average media sentiment score of 0.10 beat Akili's score of -0.22 indicating that Akili is being referred to more favorably in the media.
Summary
Retractable Technologies beats Akili on 9 of the 17 factors compared between the two stocks.
Get Retractable Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Retractable Technologies Competitors List
Related Companies and Tools
